NEW YORK (Reuters) – Supply of a malaria treatment that has been tried with some success versus the new coronavirus remains in brief supply as demand surges in the middle of the fast-spreading outbreak, according to independent drug stores and the American Society of Health-System Pharmacists (ASHP).
The ASHP, which maintains a list of drugs in shortage independent of the U.S. Food and Drug Administration’s list, plans to include the generic malaria drug hydroxychloroquine to its list of shortages later on Thursday, according to Erin Fox, senior director of drug info at University of Utah Health, who keeps the lacks list for the ASHP.
The FDA could not be i